Skip to main content

Market Overview

Tricida to Report Fourth Quarter and Year-End 2020 Financial Results and Host Conference Call and Webcast on Thursday, February 25, 2021


SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Tricida, Inc. (NASDAQ:TCDA) today announced that it will report its fourth quarter and year-end 2020 financial results after the close of market on Thursday, February 25, 2021. Tricida will host a conference call and webcast at 4:30 pm Eastern Time to discuss its fourth quarter and year-end 2020 financial results and business progress. The call or webcast may be accessed as follows:

Tricida Fourth Quarter and Year-End 2020 Conference Call
Thursday, February 25, 2021
4:30 pm Eastern Time
  Dial-in: (800) 733-2954
  International: (847) 413-3731
  Conference ID: 50111253


A replay of the webcast will be available on Tricida's website approximately two hours following the completion of the call and will be available for up to 90 days following the presentation.

About Tricida

Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of its drug candidate, veverimer (TRC101), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with CKD. Metabolic acidosis is a condition commonly caused by CKD that is believed to accelerate the progression of kidney deterioration. It is estimated to pose a health risk to approximately three million patients with CKD in the United States.

For more information about Tricida, please visit

Jackie Cossmon
Tricida, Inc.
Senior Vice President of Investor Relations and Communications

Source: Tricida, Inc.

Primary Logo

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at